Johnson & Johnson releases results from phase three single-dose COVID-19 vaccine trials ...Middle East

CBS News - Cultural
Johnson & Johnson releases results from phase three single-dose COVID-19 vaccine trials
Johnson & Johnson announced that their new single-dose vaccine showed 85% protection against severe cases of COVID-19. Some advantages of the new vaccine: it's a single dose and can be stored in a regular refrigerator. Dr.Tara Narula details how this new vaccine works.

Hence then, the article about johnson johnson releases results from phase three single dose covid 19 vaccine trials was published today ( ) and is available on CBS News ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Johnson & Johnson releases results from phase three single-dose COVID-19 vaccine trials )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Cultural


Latest News